drugset / Trial / NCT03336619
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of uncomplicated influenza.
Timeline
- Start
- 2018-01-17
- Primary completion
- 2019-04-17
- Completion
- 2019-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nitazoxanide | Other / unclassified | 600 mg | Oral |